ARTICLE | Clinical News
PPL reports additional AAT data
February 9, 2000 8:00 AM UTC
PPL (LSE:PTH) said that timed plasma concentration of its intravenous transgenic alpha-1 antitrypsin (AAT) was comparable to plasma-derived human AAT in a 12-patient Phase II study to treat AAT congen...